Catalyst Wire Dossier Catalyst Wire Dossier

CellFX nsPFA Cardiac Surgery System

· Pulse Biosciences, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CellFX nsPFA Cardiac Surgery System, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation [NA]

See pricing